Abiopharma

News list

Director Tallett Elizabeth E 🟢 acquired 8.4K shares (1 derivative) of Moderna, Inc. (MRNA) Transaction Date: May 06, 2026 | Filing ID: 000086

Full text

News bot May 8, 2026, 8:58 p.m.
🔍 Tallett Elizabeth E (Director)

Company: Moderna, Inc. (MRNA)

Report Date: 2026-05-06
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 8,371
Detailed Transactions and Holdings:
- Acquired 8,371 shares of Restricted Stock Units (Derivative)
  Date: 2026-05-06 | Code: A | equity_swap_involved: 0 | shares_owned_after: 8,371.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2
Footnotes:
- F1: Restricted stock units convert into common stock on a one-for-one basis.
- F2: The shares subject to this restricted stock unit award will vest in full on the earlier of May 6, 2027, or Moderna's next Annual Meeting of Shareholders, subject to the recipient's continued service.